Rockwell Medical (RMTI) Net Income towards Common Stockholders (2010 - 2026)

Rockwell Medical (RMTI) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$7.2 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 290.63% year-over-year to -$7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.5 million (down 2145.27% YoY) and the FY2025 annual result came in at -$11.4 million, up 86.57% from the prior year.
• Net Income towards Common Stockholders fell to -$7.2 million in Q1 2026, from -$1.7 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.5 million in Q3 2024 to a low of -$7.2 million in Q1 2026.
• A 5-year average of -$2.5 million and a median of -$1.9 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 170.82% — and 2025, when it plunged 2748.98%.
• Tracing RMTI's Net Income towards Common Stockholders over 5 years: stood at -$1.9 million in 2022, then gained by 14.93% to -$1.6 million in 2023, then soared by 76.94% to -$372000.0 in 2024, then plunged by 343.82% to -$1.7 million in 2025, then tumbled by 336.77% to -$7.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$7.2 million (Q1 2026), -$1.7 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.